US FDA approves 21 new drugs, biologics in 2010
This article was originally published in Scrip
Executive Summary
The US FDA's Center for Drug Evaluation and Research approved fewer new chemical entities and biologics in 2010 than in the two previous years, giving the thumbs up to only 21 medicines, which was down from 25 in 2009 and 24 in 2008.